- Home
- ACXP vs DUOT Comparison
ACXP vs DUOT Comparison
Compare ACXP & DUOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACXP
- DUOT
- Stock Information
- Founded
- ACXP 2017
- DUOT 1990
- Country
- ACXP United States
- DUOT United States
- Employees
- ACXP N/A
- DUOT N/A
- Industry
- ACXP Biotechnology: Pharmaceutical Preparations
- DUOT Computer Software: Prepackaged Software
- Sector
- ACXP Health Care
- DUOT Technology
- Exchange
- ACXP Nasdaq
- DUOT Nasdaq
- Market Cap
- ACXP 31.4M
- DUOT 34.8M
- IPO Year
- ACXP 2021
- DUOT N/A
- Fundamental
- Price
- ACXP $0.87
- DUOT $4.67
- Analyst Decision
- ACXP Strong Buy
- DUOT Strong Buy
- Analyst Count
- ACXP 1
- DUOT 2
- Target Price
- ACXP $12.00
- DUOT $8.00
- AVG Volume (30 Days)
- ACXP 297.3K
- DUOT 132.8K
- Earning Date
- ACXP 11-12-2024
- DUOT 11-19-2024
- Dividend Yield
- ACXP N/A
- DUOT N/A
- EPS Growth
- ACXP N/A
- DUOT N/A
- EPS
- ACXP N/A
- DUOT N/A
- Revenue
- ACXP N/A
- DUOT $7,346,014.00
- Revenue This Year
- ACXP N/A
- DUOT $33.94
- Revenue Next Year
- ACXP N/A
- DUOT $147.69
- P/E Ratio
- ACXP N/A
- DUOT N/A
- Revenue Growth
- ACXP N/A
- DUOT N/A
- 52 Week Low
- ACXP $0.72
- DUOT $1.94
- 52 Week High
- ACXP $5.28
- DUOT $6.44
- Technical
- Relative Strength Index (RSI)
- ACXP 31.17
- DUOT 48.60
- Support Level
- ACXP $0.84
- DUOT $3.96
- Resistance Level
- ACXP $0.91
- DUOT $4.49
- Average True Range (ATR)
- ACXP 0.12
- DUOT 0.53
- MACD
- ACXP 0.02
- DUOT -0.11
- Stochastic Oscillator
- ACXP 28.07
- DUOT 27.27
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.
About DUOT Duos Technologies Group Inc.
Duos Technologies Group Inc operating under its brand name duostech, designs, develops, deploys and operates intelligent technology solutions supporting rail, logistics and intermodal businesses that streamline operations, improve safety and reduce costs. The company's main offering, the Railcar Inspection Portal (RIP), provides both freight and transit railroad customers and select government agencies the ability to conduct fully automated railcar inspections of trains while they are moving at full speed. It has also developed the Automated Logistics Information System (ALIS) which automates gatehouse operations where transport trucks enter and exit large logistics and intermodal facilities. Its segments are Rail, Commercial, Governments, Banking and AI.